International Patent: ANTIBODIES THAT SPECIFICALLY BIND CLDN6 OR CD3 AND BISPECIFIC ANTIBODIES THAT SPECIFICALLY BIND CLDN6 AND CD3

GENEVA, Oct. 22 -- THIRD ARC BIO, INC. filed a patent application (US2025/051001) for “ANTIBODIES THAT SPECIFICALLY BIND CLDN6 OR CD3 AND BISPECIFIC ANTIBODIES THAT SPECIFICALLY BIND CLDN6 AND CD3”. With publication no. WO/2026/085166, here are the other details related to the patent application:

Kind: Corrected version of pamphlet [A9]

IPC: A61K 39/395

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....